Does dual HER-2 blockade treatment increase the risk of severe toxicities of special interests in breast cancer patients: A meta-analysis of randomized controlled trials

Although dual HER-2 blockade treatment could offer greater clinical efficacy in breast cancer, the risk of severe toxicities of special interest related to this combined regimen in breast cancer remained unknown. We systematically searched public databases (MEDLINE, EMBASE, Cochrane library) to iden...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Hao, Shuai, Tian, Wuguo, Gao, Bo, Jiang, Yan, Zhang, Xiaohua, Zhang, Shu, Guo, Lingji, Zhao, Jianjie, Zhang, Gang, Hu, Chunyan, Yan, Jie, Luo, Donglin
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2017
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5386734/
https://ncbi.nlm.nih.gov/pubmed/28199966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15252
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker